Literature DB >> 28079865

Differences in mortality characteristics in neonates with Down's syndrome.

C L Cua1, U Haque1, S Santoro1, L Nicholson1, C H Backes1.   

Abstract

OBJECTIVE: Neonates with Down's syndrome (nDS) may have multiple medical issues that place them at increased risk for mortality during the newborn period. Goal of this study was to determine if there are differences in baseline characteristics, medical complications or procedures performed during hospitalization between nDS who survived versus those who died during initial hospitalization. STUDY
DESIGN: Data from 2000 to 2014 were reviewed using the Pediatric Health Information Systems (PHIS) database on all DS patients admitted to the hospital <30 days postnatal life. Baseline demographics, medical complications, procedures performed and mortality were recorded. Patients were divided into nDS patients who were discharged alive (nDS-a) versus nDS patients who died (nDS-d). Multivariate logistic analysis with odds ratios was performed to determine significant predictors of death. A P<0.05 was considered significant.
RESULTS: A total of 5737 nDS were evaluated. Overall mortality was 7.5% (431/5737). nDS-d were more likely than nDS-a to have a lower birth weight (1.0 (0.9 to 1.0)), presence of a diaphragmatic hernia (6.9 (1.9 to 25.1), or a cardiac diagnosis of a pulmonary venous abnormality (6.8 (1.9 to 24.4)), Ebstein's anomaly (3.2 (1.2 to 8.5)) or left-sided obstructive lesion (2.0 (1.3 to 3.0). nDS-d were more likely to develop hydrops (5.7 (3.5 to 9.5)) and necrotizing enterocolitis (1.7 (1.2 to 2.6)). In addition, nDS-d had significantly higher odds of requiring mechanical ventilation (20.7 (9.9 to 43.1)) or extracorporeal membrane oxygenation (8.7 (4.7 to 16.1)).
CONCLUSIONS: A number of characteristics, specifically certain cardiac diagnosis, place nDS at increased risk for mortality. Furthermore, development of specific medical complications or need for particular procedures increases the odds for mortality in nDS. Caregivers should be cognizant that they are taking care of a high-risk population nDS with an increased risk for mortality if these variables are present.

Entities:  

Mesh:

Year:  2017        PMID: 28079865     DOI: 10.1038/jp.2016.246

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  34 in total

1.  Down syndrome patients with pulmonary hypertension have elevated plasma levels of asymmetric dimethylarginine.

Authors:  Clifford L Cua; Lynette K Rogers; Louis G Chicoine; Molly Augustine; Yi Jin; Patricia L Nash; Leif D Nelin
Journal:  Eur J Pediatr       Date:  2010-12-01       Impact factor: 3.183

2.  Survival and morbidity outcomes for very low birth weight infants with Down syndrome.

Authors:  Nansi S Boghossian; Nellie I Hansen; Edward F Bell; Barbara J Stoll; Jeffrey C Murray; Abbot R Laptook; Seetha Shankaran; Michele C Walsh; Abhik Das; Rosemary D Higgins
Journal:  Pediatrics       Date:  2010-11-22       Impact factor: 7.124

3.  Population-based study of congenital heart defects in Down syndrome.

Authors:  S B Freeman; L F Taft; K J Dooley; K Allran; S L Sherman; T J Hassold; M J Khoury; D M Saker
Journal:  Am J Med Genet       Date:  1998-11-16

4.  International experience with trisomy 21 infants placed on extracorporeal membrane oxygenation.

Authors:  W M Southgate; D J Annibale; T C Hulsey; D M Purohit
Journal:  Pediatrics       Date:  2001-03       Impact factor: 7.124

5.  Hirschsprung's disease in Japan: analysis of 3852 patients based on a nationwide survey in 30 years.

Authors:  Sachiyo Suita; Tomoaki Taguchi; Satoshi Ieiri; Takanori Nakatsuji
Journal:  J Pediatr Surg       Date:  2005-01       Impact factor: 2.545

6.  Survival in infants with Down syndrome, Metropolitan Atlanta, 1979-1998.

Authors:  Sonja A Rasmussen; Lee-Yang Wong; Adolfo Correa; Don Gambrell; J M Friedman
Journal:  J Pediatr       Date:  2006-06       Impact factor: 4.406

7.  Prevalence, neonatal characteristics, and first-year mortality of Down syndrome: a national study.

Authors:  Michel E Weijerman; A Marceline van Furth; Antonie Vonk Noordegraaf; Jacobus P van Wouwe; Chantal J M Broers; Reinoud J B J Gemke
Journal:  J Pediatr       Date:  2007-11-19       Impact factor: 4.406

8.  Arterial oxygenation and pulmonary arterial pressure in healthy neonates and infants at high altitude.

Authors:  S Niermeyer; E M Shaffer; E Thilo; C Corbin; L G Moore
Journal:  J Pediatr       Date:  1993-11       Impact factor: 4.406

9.  Maternal and neonatal factors and mortality in children with Down syndrome born in 1973-1980 and 1995-1998.

Authors:  C Frid; P Drott; P Otterblad Olausson; C Sundelin; G Annerén
Journal:  Acta Paediatr       Date:  2004-01       Impact factor: 2.299

10.  Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with Down syndrome.

Authors:  Michel Emile Weijerman; A Marceline van Furth; Maurike D van der Mooren; Miriam M van Weissenbruch; Lukas Rammeloo; Chantal J M Broers; Reinoud J B J Gemke
Journal:  Eur J Pediatr       Date:  2010-04-23       Impact factor: 3.183

View more
  1 in total

1.  Usefulness of Postnatal Echocardiography in Patients with Down Syndrome with Normal Fetal Echocardiograms.

Authors:  Amy Cooper; Kacy Sisco; Carl H Backes; Marc Dutro; Ruth Seabrook; Stephanie L Santoro; Clifford L Cua
Journal:  Pediatr Cardiol       Date:  2019-09-20       Impact factor: 1.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.